Coronary Artery Diseases
Conditions
Interventions
Training model group:N/A
Adjust model parameter group:N/A
Evaluation model prediction performance group:N/A
Sponsors
The First Affiliated Hospital of the Army Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1. Patients with coronary artery disease who were hospitalized and underwent PCI were selected for the study, aged 18 to 80 years, with no restriction on gender; 2. They met the diagnostic criteria for coronary atherosclerotic heart disease, with at least 1 diseased vessel stenosis >50% on imaging; 3. There was no contraindication to coronary intervention, and at least 1 diseased vessel underwent coronary intervention or treatment during the procedure.
Exclusion criteria
Exclusion criteria: 1. Unstable clinical status, unstable hemodynamic or electrocardiographic monitoring, uncontrolled arrhythmias, and those with very high early mortality in clinical assessment; 2. Severe renal insufficiency, defined as an estimated glomerular filtration rate <30 mL/min/1.73 m^2; 3. Those who are currently self-administering medications/healthcare products of unknown composition that have been ineffectively discouraged by physicians; 4. Patients with a life expectancy of no more than 1 year or causing clinical follow-up; 5. Patients with malignant tumors or malignant systemic diseases that require treatment, severe anemia, or severe infections that are difficult to correct and control; 6. Pregnant women, for women with childbearing potential (age less than 50 years, not menopausal or last menstrual cycle less than 12 months prior to screening), women who have not undergone tubal ligation, ovarian or hysterectomy, pregnancy must be excluded prior to inclusion in this study; 7. Patients who are considered by the investigator to be inappropriate for the clinical trial for patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Composite endpoint of cardiogenic death and occurrence of ISR after PCI in patients with coronary artery disease, with predominance of those who occur first; | — |
Secondary
| Measure | Time frame |
|---|---|
| Non-cardiac death;Incidence of thrombotic events associated with PCI;Contrast-associated acute kidney damage;New-onset chronic renal insufficiency;New-onset acute coronary syndrome;revascularization for various reasons;New-onset symptomatic heart failure;New-onset of various symptomatic arrhythmias;New-onset cerebrovascular accidents;Complications of other causes of thrombosis;New-onset diabetes;Severe adverse drug reactions causing early withdrawal of patients from the group;Patients' knowledge, attitude and practice(KAP) scores on secondary and tertiary prevention of CAD;Psychosocial-related scoring profile; | — |
Countries
China
Contacts
Public ContactTao Jing
The First Affiliated Hospital of the Army Medical University
Outcome results
None listed